REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma

Name: REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma
License: Public Domain

Regeneron Pharmaceuticals

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

relapsed solid tumor, refractory solid tumor, relapsed central nervous system tumor, refractory central nervous system tumor, diffuse intrinsic pontine glioma, high grade glioma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 377418
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.